Search research articles
Contact Us
Filters
Showing results (641-650 of 673) with videos related to
Page
of 68
Sort By:
Molecular Cancer Therapeutics
|
March 9, 2017
Focal Adhesion Kinase as a Potential Target in AML and MDS
Bing Z Carter, Po Yee Mak, Xiangmeng Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 21, 2019
Maintenance Defactinib Versus Placebo After First-Line Chemotherapy in Patients With Merlin-Stratified Pleural Mesothelioma: COMMAND-A Double-Blind, Randomized, Phase II Study
Dean A Fennell, Paul Baas, Paul Taylor, et al.
Gastroenterology
|
August 30, 2008
Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease
Johan Van Limbergen, Richard K Russell, Hazel E Drummond, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 18, 2023
Duvelisib Eliminates CLL B Cells, Impairs CLL-Supporting Cells, and Overcomes Ibrutinib Resistance in a Xenograft Model
Shih-Shih Chen, Jacqueline C Barrientos, Gerardo Ferrer, et al.
BMC Microbiology
|
January 14, 2016
Colonization potential to reconstitute a microbe community in patients detected early after fecal microbe transplant for recurrent C. difficile
Ranjit Kumar, Craig L Maynard, Peter Eipers, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 19, 2019
Phase 2 study of the focal adhesion kinase inhibitor defactinib (VS-6063) in previously treated advanced KRAS mutant non-small cell lung cancer
David E Gerber, D Ross Camidge, Daniel Morgensztern, et al.
Inflammatory Bowel Diseases
|
December 20, 2007
Autophagy gene ATG16L1 influences susceptibility and disease location but not childhood-onset in Crohn's disease in Northern Europe
J Van Limbergen, R K Russell, E R Nimmo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 25, 2012
Cisplatin benefit is predicted by immunohistochemical analysis of DNA repair proteins in squamous cell carcinoma but not adenocarcinoma: theranostic modeling by NSCLC constituent histological subclasses
W E Pierceall, K A Olaussen, V Rousseau, et al.
JCI Insight
|
November 19, 2020
Bone marrow Tregs mediate stromal cell function and support hematopoiesis via IL-10
Virginia Camacho, Victoria R Matkins, Sweta B Patel, et al.
Nature
|
July 7, 2009
The AP-1 transcription factor Batf controls T(H)17 differentiation
Barbara U Schraml, Kai Hildner, Wataru Ise, et al.
Page
of 68
Search research articles
Search
Showing results (641-650 of 673) with videos related to
Sort By:
Page
of 68
Molecular Cancer Therapeutics
|
March 9, 2017
Focal Adhesion Kinase as a Potential Target in AML and MDS
Bing Z Carter, Po Yee Mak, Xiangmeng Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 21, 2019
Maintenance Defactinib Versus Placebo After First-Line Chemotherapy in Patients With Merlin-Stratified Pleural Mesothelioma: COMMAND-A Double-Blind, Randomized, Phase II Study
Dean A Fennell, Paul Baas, Paul Taylor, et al.
Gastroenterology
|
August 30, 2008
Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease
Johan Van Limbergen, Richard K Russell, Hazel E Drummond, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 18, 2023
Duvelisib Eliminates CLL B Cells, Impairs CLL-Supporting Cells, and Overcomes Ibrutinib Resistance in a Xenograft Model
Shih-Shih Chen, Jacqueline C Barrientos, Gerardo Ferrer, et al.
BMC Microbiology
|
January 14, 2016
Colonization potential to reconstitute a microbe community in patients detected early after fecal microbe transplant for recurrent C. difficile
Ranjit Kumar, Craig L Maynard, Peter Eipers, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 19, 2019
Phase 2 study of the focal adhesion kinase inhibitor defactinib (VS-6063) in previously treated advanced KRAS mutant non-small cell lung cancer
David E Gerber, D Ross Camidge, Daniel Morgensztern, et al.
Inflammatory Bowel Diseases
|
December 20, 2007
Autophagy gene ATG16L1 influences susceptibility and disease location but not childhood-onset in Crohn's disease in Northern Europe
J Van Limbergen, R K Russell, E R Nimmo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 25, 2012
Cisplatin benefit is predicted by immunohistochemical analysis of DNA repair proteins in squamous cell carcinoma but not adenocarcinoma: theranostic modeling by NSCLC constituent histological subclasses
W E Pierceall, K A Olaussen, V Rousseau, et al.
JCI Insight
|
November 19, 2020
Bone marrow Tregs mediate stromal cell function and support hematopoiesis via IL-10
Virginia Camacho, Victoria R Matkins, Sweta B Patel, et al.
Nature
|
July 7, 2009
The AP-1 transcription factor Batf controls T(H)17 differentiation
Barbara U Schraml, Kai Hildner, Wataru Ise, et al.
Page
of 68